168 related articles for article (PubMed ID: 24577895)
1. Methylation of tumor suppressor genes in a novel panel predicts clinical outcome in paraffin-embedded bladder tumors.
García-Baquero R; Puerta P; Beltran M; Alvarez-Mújica M; Alvarez-Ossorio JL; Sánchez-Carbayo M
Tumour Biol; 2014 Jun; 35(6):5777-86. PubMed ID: 24577895
[TBL] [Abstract][Full Text] [Related]
2. Methylation of a novel panel of tumor suppressor genes in urine moves forward noninvasive diagnosis and prognosis of bladder cancer: a 2-center prospective study.
García-Baquero R; Puerta P; Beltran M; Alvarez M; Sacristan R; Alvarez-Ossorio JL; Sánchez-Carbayo M
J Urol; 2013 Aug; 190(2):723-30. PubMed ID: 23485510
[TBL] [Abstract][Full Text] [Related]
3. Multiplexed methylation profiles of tumor suppressor genes and clinical outcome in lung cancer.
Castro M; Grau L; Puerta P; Gimenez L; Venditti J; Quadrelli S; Sánchez-Carbayo M
J Transl Med; 2010 Sep; 8():86. PubMed ID: 20849603
[TBL] [Abstract][Full Text] [Related]
4. Molecular classification of non-muscle-invasive bladder cancer (pTa low-grade, pT1 low-grade, and pT1 high-grade subgroups) using methylation of tumor-suppressor genes.
Sacristan R; Gonzalez C; Fernández-Gómez JM; Fresno F; Escaf S; Sánchez-Carbayo M
J Mol Diagn; 2014 Sep; 16(5):564-572. PubMed ID: 24998186
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the methylation status of tumour suppressor genes for predicting bacillus Calmette-Guérin response in patients with T1G3 high-risk bladder tumours.
Agundez M; Grau L; Palou J; Algaba F; Villavicencio H; Sanchez-Carbayo M
Eur Urol; 2011 Jul; 60(1):131-40. PubMed ID: 21514719
[TBL] [Abstract][Full Text] [Related]
6. Multiplexed methylation profiles of tumor suppressor genes in bladder cancer.
Cabello MJ; Grau L; Franco N; Orenes E; Alvarez M; Blanca A; Heredero O; Palacios A; Urrutia M; Fernández JM; López-Beltrán A; Sánchez-Carbayo M
J Mol Diagn; 2011 Jan; 13(1):29-40. PubMed ID: 21227392
[TBL] [Abstract][Full Text] [Related]
7. KISS1 methylation and expression as tumor stratification biomarkers and clinical outcome prognosticators for bladder cancer patients.
Cebrian V; Fierro M; Orenes-Piñero E; Grau L; Moya P; Ecke T; Alvarez M; Gil M; Algaba F; Bellmunt J; Cordon-Cardo C; Catto J; López-Beltrán A; Sánchez-Carbayo M
Am J Pathol; 2011 Aug; 179(2):540-6. PubMed ID: 21683672
[TBL] [Abstract][Full Text] [Related]
8. DNA Methylation profiles as predictors of recurrence in non muscle invasive bladder cancer: an MS-MLPA approach.
Casadio V; Molinari C; Calistri D; Tebaldi M; Gunelli R; Serra L; Falcini F; Zingaretti C; Silvestrini R; Amadori D; Zoli W
J Exp Clin Cancer Res; 2013 Nov; 32(1):94. PubMed ID: 24252461
[TBL] [Abstract][Full Text] [Related]
9. Clinical significance of protocadherin 8 (PCDH8) promoter methylation in non-muscle invasive bladder cancer.
Lin YL; Wang YL; Ma JG; Li WP
J Exp Clin Cancer Res; 2014 Aug; 33(1):68. PubMed ID: 25927589
[TBL] [Abstract][Full Text] [Related]
10. RUNX3 methylation as a predictor for disease progression in patients with non-muscle-invasive bladder cancer.
Yan C; Kim YW; Ha YS; Kim IY; Kim YJ; Yun SJ; Moon SK; Bae SC; Kim WJ
J Surg Oncol; 2012 Mar; 105(4):425-30. PubMed ID: 22311819
[TBL] [Abstract][Full Text] [Related]
11. Methylation status as a predictor of intravesical Bacillus Calmette-Guérin (BCG) immunotherapy response of high grade non-muscle invasive bladder tumor.
Husek P; Pacovsky J; Chmelarova M; Podhola M; Brodak M
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2017 Jun; 161(2):210-216. PubMed ID: 28344356
[TBL] [Abstract][Full Text] [Related]
12. Methylation of the RUNX3 promoter as a potential prognostic marker for bladder tumor.
Kim EJ; Kim YJ; Jeong P; Ha YS; Bae SC; Kim WJ
J Urol; 2008 Sep; 180(3):1141-5. PubMed ID: 18639281
[TBL] [Abstract][Full Text] [Related]
13. Regularly methylated novel pro-apoptotic genes associated with recurrence in transitional cell carcinoma of the bladder.
Christoph F; Weikert S; Kempkensteffen C; Krause H; Schostak M; Miller K; Schrader M
Int J Cancer; 2006 Sep; 119(6):1396-402. PubMed ID: 16642478
[TBL] [Abstract][Full Text] [Related]
14. Polyamine-modulated factor-1 methylation predicts Bacillus Calmette-Guérin response in patients with high-grade non-muscle-invasive bladder carcinoma.
Alvarez-Múgica M; Fernández-Gómez JM; Cebrian V; Fresno F; Escaf S; Sánchez-Carbayo M
Eur Urol; 2013 Feb; 63(2):364-70. PubMed ID: 22682992
[TBL] [Abstract][Full Text] [Related]
15. Ras association domain family 1A: a promising prognostic marker in recurrent nonmuscle invasive bladder cancer.
Kim JS; Chae Y; Ha YS; Kim IY; Byun SS; Yun SJ; Kim WJ
Clin Genitourin Cancer; 2012 Jun; 10(2):114-20. PubMed ID: 22382007
[TBL] [Abstract][Full Text] [Related]
16. Quantitation of promoter methylation of multiple genes in urine DNA and bladder cancer detection.
Hoque MO; Begum S; Topaloglu O; Chatterjee A; Rosenbaum E; Van Criekinge W; Westra WH; Schoenberg M; Zahurak M; Goodman SN; Sidransky D
J Natl Cancer Inst; 2006 Jul; 98(14):996-1004. PubMed ID: 16849682
[TBL] [Abstract][Full Text] [Related]
17. RSPH9 methylation pattern as a prognostic indicator in patients with non-muscle invasive bladder cancer.
Yoon HY; Kim YJ; Kim JS; Kim YW; Kang HW; Kim WT; Yun SJ; Ryu KH; Lee SC; Kim WJ
Oncol Rep; 2016 Feb; 35(2):1195-203. PubMed ID: 26575865
[TBL] [Abstract][Full Text] [Related]
18. Characteristic patterns of altered DNA methylation predict emergence of human hepatocellular carcinoma.
Nishida N; Kudo M; Nagasaka T; Ikai I; Goel A
Hepatology; 2012 Sep; 56(3):994-1003. PubMed ID: 22407776
[TBL] [Abstract][Full Text] [Related]
19. Stratification based on methylation of TBX2 and TBX3 into three molecular grades predicts progression in patients with pTa-bladder cancer.
Beukers W; Kandimalla R; Masius RG; Vermeij M; Kranse R; van Leenders GJ; Zwarthoff EC
Mod Pathol; 2015 Apr; 28(4):515-22. PubMed ID: 25394776
[TBL] [Abstract][Full Text] [Related]
20. Methylation-specific multiplex ligation-dependent probe amplification and its impact on clinical findings in medulloblastoma.
Feierabend D; Walter J; Grube S; Herbold C; Beetz C; Kalff R; Ewald C
J Neurooncol; 2014 Jan; 116(2):213-20. PubMed ID: 24162828
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
